By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Synthetic Genomics and Plenus today announced the formation of a new firm, Agradis, to develop and commercialize products that leverage new technologies in genomics and plant breeding.

The companies also announced Agradis has raised $20 million in a Series A financing round to establish a corporate infrastructure and to support product development and commercialization.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In a series of articles, medical journals debate the necessity of conflict-of-interest policies.

Irwin Rose, who won the 2004 Nobel Prize in Chemistry for his work on ubiquitin-mediated protein degradation, has died.

In Cell this week: biobank of colorectal cancer organoids, ancient wolf genome analysis, and more.

With cloud computing becoming more attractive to researchers, Nature News offers some tips on how to get going.